Trial intelligence / Profile preview

High Dose Steroids for Dysphagia After Anterior Spinal Surgery

NCT03256149Withdrawn

Sponsor
Centre hospitalier de l’Université de Montréal
Start
Mar 2015
Primary completion
Nov 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of dexamethasone in dysphagia (2 arms), sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoints: Voice evaluation at 1 day, Dysphagia evaluation: Modified Barium Swallow Impairment Profile at 1 day and 3 more. Planned start Mar 2015; status: withdrawn.

02

Drugs

dexamethasone
03

Conditions

dysphagia

Beyond the preview

Go deeper on NCT03256149.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03256149.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call